| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.2B | $36.2B | $36.0B | $32.3B | $29.1B | $6.2B | $6.7B | $6.3B |
| Cost of Revenue | — | — | — | — | — | — | $8.5B | $10.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.9B | $5.4B | $5.9B | $4.6B | $4.9B | $0.6B | $1.1B | $1.0B |
| Net Income | $1.9B | $3.8B | $4.1B | $3.3B | $4.2B | $0.4B | $0.8B | $0.8B |
| EPS (Basic) | $1.63 | $3.32 | $3.60 | $2.85 | $3.57 | $0.79 | $2.95 | $3.27 |
| EPS (Diluted) | $1.63 | $3.31 | $3.58 | $2.83 | $3.54 | $0.33 | $0.67 | $0.56 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.0B | $31.3B | $29.4B | $28.0B | $31.4B | $29.4B | $19.2B | $24.2B |
| Current Assets | $7.4B | $6.8B | $7.3B | $7.0B | $9.8B | $7.8B | $5.7B | $12.5B |
| Cash & Equivalents | — | — | — | — | $6.5B | $4.4B | $2.7B | $8.8B |
| Total Liabilities | $40.1B | $38.8B | $37.4B | $36.7B | $36.7B | $37.2B | $25.5B | $23.0B |
| Current Liabilities | $10.2B | $9.1B | $9.3B | $9.2B | $8.2B | $7.3B | $6.2B | $5.7B |
| Stockholders' Equity | $-8.1B | $-7.4B | $-8.0B | $-8.7B | $-5.3B | $-7.8B | $-6.2B | $1.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.7B | $6.1B | $6.0B | $4.4B | $6.0B | $1.6B | $5.0B | $11.9B |
| Investing Cash Flow | $-2.5B | $-2.7B | $-2.3B | $-2.1B | $-0.3B | $-1.7B | $-1.0B | $-2.4B |
| Capital Expenditures | $2.3B | $2.8B | $2.3B | $1.8B | $1.5B | $1.5B | $1.8B | $2.0B |
| Financing Cash Flow | $-2.3B | $-3.7B | $-3.0B | $-5.6B | $-3.7B | $1.7B | $-10.1B | $-3.2B |